TRANSCODE THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $20.4M | $20.8M |
| FY2022 | — | $3.2M | $5.0M |
| FY2023 | — | $1.6M | $2.8M |
| FY2024 | — | $-2.0M | $5.8M |
| FY2025 | — | $10.3M | $17.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $20.4M | $20.8M |
| FY2022 | — | $3.2M | $5.0M |
| FY2023 | — | $1.6M | $2.8M |
| FY2024 | — | $-2.0M | $5.8M |
| FY2025 | — | $10.3M | $17.8M |